Danielle Watson - Heart Test CFO Treasurer

HSCS Stock  USD 2.67  0.05  1.91%   

Insider

Danielle Watson is CFO Treasurer of Heart Test Laboratories
Age 42
Address 550 Reserve Street, Southlake, TX, United States, 76092
Phone682-237-7781
Webhttps://heartsciences.com

Heart Test Management Efficiency

The company has return on total asset (ROA) of (0.8169) % which means that it has lost $0.8169 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.6929) %, meaning that it created substantial loss on money invested by shareholders. Heart Test's management efficiency ratios could be used to measure how well Heart Test manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.88 in 2024. Return On Capital Employed is likely to drop to -0.85 in 2024. At this time, Heart Test's Total Assets are comparatively stable compared to the past year. Net Tangible Assets is likely to gain to about 217.5 K in 2024, whereas Intangible Assets are likely to drop slightly above 1.3 M in 2024.
Heart Test Laboratories currently holds 1.04 M in liabilities with Debt to Equity (D/E) ratio of 0.41, which is about average as compared to similar companies. Heart Test Laboratories has a current ratio of 3.46, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Heart Test's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Christopher YamamotoBioventus
N/A
Sanjay AhujaTivic Health Systems
N/A
Miguel BeltranDelgadoBioventus
N/A
Richard GinnTenon Medical
58
Katherine TwedenReShape Lifesciences
63
William MDNuwellis
N/A
Kenneth RealiBioventus
58
Kevin VanceBluejay Diagnostics
66
Rony AloniInspira Technologies Oxy
N/A
Jennifer ErnstTivic Health Systems
56
Laurent DuhouxNuwellis
N/A
Kenneth CPABluejay Diagnostics
44
Mark KnudsonReShape Lifesciences
75
Shunichi KurodaBone Biologics Corp
N/A
DVM DVMReShape Lifesciences
N/A
Mark FeinbergBluejay Diagnostics
N/A
Ryan SabiaTivic Health Systems
37
Mark MDBluejay Diagnostics
N/A
Anthony JamesBioventus
N/A
Blake GurfeinTivic Health Systems
40
Rob ScottNuwellis
N/A
Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company was incorporated in 2007 and is headquartered in Southlake, Texas. Heart Test operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 12 people. Heart Test Laboratories (HSCS) is traded on NASDAQ Exchange in USA. It is located in 550 Reserve Street, Southlake, TX, United States, 76092 and employs 15 people. Heart Test is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Heart Test Laboratories Management Team

Elected by the shareholders, the Heart Test's board of directors comprises two types of representatives: Heart Test inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Heart. The board's role is to monitor Heart Test's management team and ensure that shareholders' interests are well served. Heart Test's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Heart Test's outside directors are responsible for providing unbiased perspectives on the board's policies.
Danielle Watson, CFO Treasurer
Andrew Simpson, President CEO
Mark Hilz, Secretary COO

Heart Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Heart Test a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Heart Stock Analysis

When running Heart Test's price analysis, check to measure Heart Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heart Test is operating at the current time. Most of Heart Test's value examination focuses on studying past and present price action to predict the probability of Heart Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heart Test's price. Additionally, you may evaluate how the addition of Heart Test to your portfolios can decrease your overall portfolio volatility.